huXBR1-402-G5-PNU

N/A

Report date: 2022/10/23 11:01:53

Base Information

Drug NamehuXBR1-402-G5-PNU
Drug Alias NamehuXBR1-402-PNU
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonistsWnt signalling pathway modulators
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNbe-Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesNbe-Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A